idh inhibitors in relapsed/refractory aml
Published 1 year ago • 187 plays • Length 42:38Download video MP4
Download video MP3
Similar videos
-
1:48
idh1 inhibitor ivosidenib for the treatment of relapsed/ refractory aml
-
1:32
idh inhibitors for aml and mds
-
8:50
idh inhibitors for aml
-
47:16
impact of a best practices program in patients with relapsed/refractory mm receiving selinexor
-
1:53
the promising role of idh inhibitors in aml
-
1:27
how do targeted treatments for idh1 and idh2 mutations work in acute myeloid leukemia (aml)?
-
5:29
case 3: idh inhibitors for the treatment of aml
-
2:57
targeting idh mutations for the treatment of aml
-
45:25
comy online 2020 - session 16
-
2:22
session highlights: idh inhibitors, salvage regimens, and other novel developments in aml
-
2:01
phase ii trial of enasidenib in idh2-mutant mds
-
1:11
are idh mutations good minimal residual disease (mrd) markers in acute myeloid leukemia (aml)?
-
43:39
post ash22 mpn summary
-
2:13
a success story: idh inhibitors for aml
-
52:12
the 1st online master class in transplantation and hematology (math) - session 1
-
56:54
post-hct relapse monitoring and management
-
1:04:39
best of ash22 aml
-
2:50
idh inhibition in aml therapy